FOXP3 and neoplasm: Deng et al. [11] reported that 31 small molecule compounds, including GA, can downregulate the expression of Treg's key transcription factor FOXP3, thereby, altering the tumor's immunosuppressive environment and slowing down the progression of colorectal cancer.